- Austria / Österreich
- Bosnia and Herzegovina / Босна и Херцеговина
- Bulgaria / България
- Croatia / Hrvatska
- Czech Republic & Slovakia / Česká republika & Slovensko
- France / France
- Germany / Deutschland
- Greece / ΕΛΛΑΔΑ
- Italy / Italia
- Netherlands / Nederland
- Nordic / Nordic
- Poland / Polska
- Portugal / Portugal
- Romania & Moldova / România & Moldova
- Slovenia / Slovenija
- Serbia & Montenegro / Србија и Црна Гора
- Spain / España
- Switzerland / Schweiz
- Turkey / Türkiye
- UK & Ireland / UK & Ireland
NEW YORK/LEIPZIG, Germany: The US Food and Drug Administration have has given clearance for Genesis, a new implant system developed by Keystone Dental in Burlington, Massachusetts, in the United States. The new system is said to improve the aesthetic outcome of implant procedures through a pink implant collar called AnaTite. It also offers a new nano-surface that mimics the structure of bone and improves osseointegration, the company says.
Keystone offers a variety of dental products including the PRIMA implant which the company acquired from an aquisition of Lifecore Biomedical in 2008. The FDA clearance will give the company the right to market Genesis immediately in the combined North American markets. According to the company, it is expected to be launched in Europe in February 2011.
Fri. 26 April 2024
12:00 PM EST (New York)
How you can access data-driven decision making
Mon. 29 April 2024
12:30 PM EST (New York)
Root caries: The challenge in today’s cariology
Tue. 30 April 2024
1:00 PM EST (New York)
Neodent Discovery: Neoarch Guided Surgery—from simple to complex cases
Fri. 3 May 2024
1:00 PM EST (New York)
Osseointegration in extrēmus: Complex maxillofacial reconstruction & rehabilitation praeteritum, praesens et futurum
Tue. 7 May 2024
8:00 PM EST (New York)
You got this! Diagnosis and management of common oral lesions
Thu. 9 May 2024
8:00 PM EST (New York)
Empowering your restorative practice: A comprehensive guide to clear aligner integration and success
Mon. 13 May 2024
9:00 AM EST (New York)
To post a reply please login or register